1291094-73-9

1291094-73-9 structure
1291094-73-9 structure
  • Name: Licogliflozin
  • Chemical Name: Licogliflozin
  • CAS Number: 1291094-73-9
  • Molecular Formula: C23H28O7
  • Molecular Weight: 416.46
  • Catalog: Signaling Pathways Membrane Transporter/Ion Channel SGLT
  • Create Date: 2018-05-14 00:12:45
  • Modify Date: 2026-07-13 13:40:55
  • Licogliflozin is a sodium glucose cotransporter (SGLT1 and SGLT2) inhibitor.

Name Licogliflozin
Synonyms (2S,3R,4R,5S,6R)-2-[3-(2,3-DIHYDRO-BENZO[1,4]DIOXIN-6-YLMETHYL)-4-ETHYL-PHENYL]-6-HYDROXYMETHYL-TETR
LIK066
D-Glucitol, 1,5-anhydro-1-C-[3-[(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]-4-ethylphenyl]-, (1S)
SGLT,LIK 066,LIK-066,Licogliflozin,inhibit,Sodium-dendent glucose cotransporters,Inhibitor
Licogliflozin (LIK066)
(2S,3R,4R,5S,6R)-2-[3-(2,3-dihydro-benzo[1,4]dioxin-6-ylmethyl)-4-ethyl-phenyl]-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol
licogliflozin bis(prolinate)
(2S,3R,4R,5S,6R)-2-(3-((2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)methyl)-4-ethylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
Description Licogliflozin is a sodium glucose cotransporter (SGLT1 and SGLT2) inhibitor.
Related Catalog
Target

SGLT1, SGLT2[1]

In Vitro Licogliflozin (LIK066) is a non-anti-fibrotic treatment agent for non-alcoholic steatohepatitis (NASH).
References

[1]. Monica A. Konerman, et al. Overview of Clinical Treatment Trials for NASH.Curr Hepatol Rep. 2017 Dec;16(4): 366-373.

Molecular Formula C23H28O7
Molecular Weight 416.46
Storage condition 2-8℃
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.